Revolution Medicines, Inc. Common Stock

RVMD · Biotechnology · $40.9B
Cooling off
RVMD
$190.95
▼ −3.04%
09/18 O 197.00 H 197.10 L 188.18 C 190.95 ▼ −3.04%
Vol 5.9M RS 97
RS rating97
Now vs pivot (%)−14.87%
Tightening (ATR ratio)1.24×
Volume dry-up0.91×
Up/down volume, net-0.05
From 52-week high15%
forming
Previous breakout trailed out ▲ +43.74% in Apr
Cooling off
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

The read

The base has run 3.2 weeks and fell 16% from its ceiling at its deepest. The pivot is $224.31, and the stock closed 14.9% below it. Its relative strength rating is 97.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 47d
    Quarterly earnings
    Nov 4, 2026
Flagged by the market sweep
Several insiders soldInsider · 2026-09-18
5 insiders sold $66,741,052
Several insiders soldInsider · 2026-09-17
5 insiders sold $66,741,052
Several insiders soldInsider · 2026-09-16
5 insiders sold $66,741,052
Several insiders soldInsider · 2026-09-15
4 insiders sold $48,016,285
Several insiders soldInsider · 2026-09-12
3 insiders sold $44,862,478
Several insiders soldInsider · 2026-09-11
3 insiders sold $44,862,478

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
Revolution Medicines, Inc. Common Stock (RVMD) — The Tape